CLINICAL MEDICAL REAGENTS USE
| Brand | Owner (click to sort) | Address | Description |
|---|---|---|---|
| BETOVAC | Oxford BioMedica plc | Windrush Court, Transport Way Oxford OX46LT United Kingdom | clinical medical reagents for use in gene therapy; pharmaceutical preparations for use in gene therapy; therapeutic compositions containing lipsome reagents suitable for gene therapy; therapeutic compositions containing nucleic acid for gene therapy; pharmaceutical preparations containing nucleic acids for use in the treatment of viral and bacterial infections, cancer, HIV and aids related infections and bodily conditions associated with impaired immunosystems; pharmaceutical preparations in the field of gene therapy, pharmaceutical preparations for the treatment of cancer;chemical compositions containing nucleic acids for use in the manufacture of pharmaceuticals and retroviral vector preparations;instruments and apparatus for the administration of gene therapy, namely, syringes, scalpels, catheters, tubes for the administration of gene therapy, except for containers for receiving of a patient's blood; |
| BETOVAC | Oxford BioMedica plc | Windrush Court, Transport Way Oxford OX46LT United Kingdom | Clinical medical reagents for use in gene therapy; pharmaceutical preparations, namely, vaccines, for use in gene therapy; therapeutic compositions containing lipsome reagents or nucleic acid suitable for gene therapy; pharmaceutical preparations containing nucleic acids for use in the treatment of viral and bacterial infections, cancer, HIV and aids related infections and bodily conditions associated with impaired immunosystems, single gene disorders, hemophilia, blood disorders, vascular disorders and disorders arising from inappropriate vascularisation, diseases of the nervous system, cardiac disorders, inflammatory and auto-immune diseases; pharmaceutical preparations, namely, vaccines, for use in the treatment of cancer, single gene disorders, hemophilia, blood disorders, vascular disorders and disorders arising from inappropriate vascularisation, diseases of the nervous system, cardiac disorders, inflammatory and auto-immune diseases; enzymes and enzyme preparations for medical purposes; retroviral vector and retroviral vector manufacturing preparations; chemotherapeutics for medical use;Instruments and apparatus for the administration of gene therapy products, namely, Pre-filled vials, syringes and injectors, catheters, and tubes; surgical and medical apparatus and instruments, namely, scalpels, knives, forceps and surgical clips; |
| CHANEX | Oxford BioMedica plc | Windrush Court, Transport Way Oxford OX46LT United Kingdom | CLINICAL MEDICAL REAGENTS FOR USE IN GENE THERAPY; PHARMACEUTICAL PREPARATIONS FOR USE IN GENE THERAPY; THERAPEUTIC COMPOSITIONS CONTAINING LIPOSOME REAGENTS SUITABLE FOR GENE THERAPY; THERAPUETIC COMPOSITIONS CONTAINING NUCLEIC ACIDS FOR GENE THERAPY; PHARMACEUTICAL PREPARATIONS CONTAINING NUCLEIC ACID FOR USE IN THE TREATMENT OF CANCER, HIV AND AIDS-RELATED INFECTIONS AND BODILY CONDITIONS ASSOCIATED WITH IMPAIRED IMMUNOSYSTEMS, VIRAL AND BACTIERIAL DISEASES, CANCER AND CYSTIC FIBROSIS; PHARMACEUTICAL PREPARATIONS IN THE FIELD OF GENE THERAPY; PHARMACUETICAL PREPARATIONS FOR THE TREATMENT OF CYSTIC FIBROSIS;INSTRUMENTS AND APPARATUS FOR THE ADMINISTRATION OF GENE THERAPY, NAMELY, SYRINGES, SCALPELS, CATHETERS, TUBES FOR THE ADMINISTRATION OF GENE THERAPY PRODUCTS; SURGICAL AND MEDICAL APPARATUS AND INSTRUMENTS, NAMELY, SYRINGES, SCALPELS, CATHETERS AND TUBES FOR MEDICAL SERVICES;genetic engineering services and biotechnology services, namely, development and commercialization of therapeutic vaccines and gene-based therapies in respect of oncology and neurotherapy; |
| CORECTOGEN | Oxford BioMedica plc | Windrush Court, Transport Way Oxford OX46LT United Kingdom | CLINICAL MEDICAL REAGENTS FOR USE IN GENE THERAPY; PHARMACEUTICAL PREPARATIONS FOR USE IN GENE THERAPY; THERAPEUTIC COMPOSITIONS CONTAINING LIPSOME REAGENTS SUITABLE FOR GENE THERAPY; THERAPEUTIC COMPOSITIONS CONTAINING NUCLEIC ACID FOR GENE THERAPY; PHARMACEUTICAL PREPARATIONS CONTAINING NUCLEIC ACIDS FOR USE IN THE TREATMENT OF VIRAL AND BACTERIAL INFECTIONS, CANCER, HIV AND AIDS RELATED INFECTIONS AND BODILY CONDITIONS ASSOCIATED WITH IMPAIRED IMMUNOSYSTEMS; PHARMACEUTICAL PREPARATIONS IN THE FIELD OF GENE THERAPY; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CANCER;CHEMICAL COMPOSITIONS CONTAINING NUCLEIC ACIDS FOR USE IN THE MANUFACTURE OF PHARMACEUTICALS AND RETROVIRAL VECTOR PREPARATIONS;INSTRUMENTS AND APPARATUS FOR THE ADMINISTRATION OF GENE THERAPY, NAMELY, SYRINGES, SCALPELS, CATHETERS, TUBES FOR THE ADMINISTRATION OF GENE THERAPY PRODUCTS; SURGICAL AND MEDICAL APPARATUS AND INSTRUMENTS FOR THE ADMINISTRATION OF GENE THERAPY PRODUCTS, NAMELY, SYRINGES, SCALPELS, INJECTORS, CATHETERS, TUBES FOR THE ADMINISTRATION OF GENE THERAPY PRODUCTS; |
| GLIOSTAT | Oxford BioMedica plc | Windrush Court, Transport Way Oxford OX46LT United Kingdom | clinical medical reagents for use in gene therapy; pharmaceutical preparations for use in gene therapy; therapeutic compositions containing lipsome reagents suitable for gene therapy; therapeutic compositions containing nucleic acid for gene therapy; pharmaceutical preparations containing nucleic acids for use in the treatment of viral and bacterial infections, cancer, HIV and aids related infections and bodily conditions associated with impaired immunosystems; pharmaceutical preparations in the field of gene therapy; pharmaceutical preparations for the treatment of cancer;chemical compositions containing nucleic acids for use in the manufacture of pharmaceuticals and retroviral vector preparations;instruments and apparatus for the administration of gene therapy, namely, syringes, scalpels, catheters, tubes for the administration of gene therapy products; surgical and medical apparatus and instruments for the administration of gene therapy products; |
|
|
|||
| HEPXIA | Oxford BioMedica plc | Windrush Court, Transport Way Oxford OX46LT United Kingdom | CLINICAL MEDICAL REAGENTS FOR USE IN GENE THERAPY; PHARMACEUTICAL PREPARATIONS FOR USE IN GENE THERAPY; THERAPEUTIC COMPOSITIONS CONTAINING LIPOSOME REAGENTS SUITABLE FOR GENE THERAPY; THERAPEUTIC COMPOSITIONS CONTAINING NUCLEIC ACIDS FOR GENE THERAPY; PHARMACEUTICAL PREPARATIONS CONTAINING NUCLEIC ACIDS FOR USE IN THE TREATMENT OF VIRAL AND BACTERIAL INFECTIONS, CANCER, HIV AND AIDS RELATED INFECTIONS AND BODILY CONDITIONS ASSOCIATED WITH IMPAIRED IMMUNOSYSTEMS; PHARMACEUTICAL PREPARATIONS IN THE FIELD OF GENE THERAPY; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CANCER;CHEMICAL COMPOSITIONS CONTAINING NUCLEIC ACIDS FOR USE IN THE MANUFACTURE OF GENE THERAPY PREPARATIONS;INSTRUMENTS AND APPARATUS FOR THE ADMINISTRATION OF GENE THERAPY NAMELY, SYRINGES, SCALPELS, CATHETERS, TUBES FOR THE ADMINISTRATION OF GENE THERAPY PRODUCTS; |
| HEPXIA | Oxford BioMedica plc | Windrush Court, Transport Way Oxford OX46LT United Kingdom | CLINICAL MEDICAL REAGENTS FOR USE IN GENE THERAPY; PHARMACEUTICAL PREPARATIONS FOR USE IN GENE THERAPY; THERAPEUTIC COMPOSITIONS CONTAINING LIPOSOME REAGENTS SUITABLE FOR GENE THERAPY; THERAPEUTIC COMPOSITIONS CONTAINING NUCLEIC ACIDS FOR GENE THERAPY; PHARMACEUTICAL PREPARATIONS CONTAINING NUCLEIC ACIDS FOR USE IN THE TREATMENT OF VIRAL AND BACTERIAL INFECTIONS, CANCER, HIV AND AIDS RELATED INFECTIONS AND BODILY CONDITIONS ASSOCIATED WITH IMPAIRED IMMUNOSYSTEMS; PHARMACEUTICAL PREPARATIONS IN THE FIELD OF GENE THERAPY; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CANCER;CHEMICAL COMPOSITIONS CONTAINING NUCLEIC ACIDS FOR USE IN THE MANUFACTURE OF GENE THERAPY PREPARATIONS;INSTRUMENTS AND APPARATUS FOR THE ADMINISTRATION OF GENE THERAPY, NAMELY, SYRINGES, SCALPELS, CATHETERS, TUBES FOR THE ADMINISTRATION OF GENE THERAPY PRODUCTS;SCIENTIFIC AND MEDICAL RESEARCH AND DEVELOPMENT, MEDICAL SERVICES, GENETIC ENGINEERING SERVICES, BIOTECHNOLOGY SERVICES ALL IN RELATION TO THE TREATMENT OF VIRAL AND BACTERIAL INFECTIONS, CANCER, HIV AND AIDS RELATED INFECTIONS AND BODILY CONDITIONS ASSOCIATED WITH IMPAIRED IMMUNOSYSTEMS; |
| IMMSTAT | Oxford BioMedica plc | Windrush Court, Transport Way Oxford OX46LT United Kingdom | clinical medical reagents for use in gene therapy pharmaceutical preparations for use in gene therapy; therapeuctic compositions containing lipsome reagents suitable for gene therapy; therapeutic compositions containing nucleic acid for gene therapy; pharmaceutical preparations containing nucleic acids for use in the treatment of viral and bacterial infections, cancer, HIV and aids related infections and bodily conditions associated with impaired immunosystems; pharmaceutical preparations in the field of gene therapy; pharmaceutical preparations for the treatment of cancer;chemical compositions containing nucleic acids for use in the manufacture of pharmaceuticals and retroviral vector preparations;instruments and apparatus for the administration of gene therapy, namely, syringes, scalpels, catheters, tubes for the administration of gene therapy products; surgical and medical apparatus and instruments for the administration of gene therapy products; |
| LENTIVECTOR | Oxford BioMedica plc | Windrush Court, Transport Way Oxford OX46LT United Kingdom | Clinical medical reagents for use in gene therapy; [ pharmaceutical preparations for use in gene therapy; therapeutic compositions containing retroviral vector preparations and/or nucleic acid suitable for gene therapy; ] retroviral vector preparations for use in gene therapy [ ; pharmaceutical preparations containing a retroviral vector delivering genes to cells for use in the treatment of viral and bacterial infections, cancer, HIV and AIDS, neurodegenerative diseases, diseases of the eye, leukemia and bodily conditions associated with impaired immunosystems ];Chemical compositions containing nucleic acids for use in the manufacture of pharmaceuticals and retroviral vector preparations;Scientific and medical research and development; genetic engineering services, biotechnology services, namely, research and development of new products in the field of biotechnology; |
| MACROGEN | (OSI) EYETECH, INC. | 12th Floor 3 Times Square New York NY 10036 | Clinical medical reagents for use in gene therapy; pharmaceutical preparations for use in gene therapy; therapeutic compositions containing liposome reagents suitable for gene therapy; therapeutic compositions containing nucleic acid for gene therapy; pharmaceutical preparations containing nucleic acid for a system delivering genes to non-dividing cells for use in the treatment of viral and bacterial infections, cancer, HIV and AIDS related infections, leukemia and bodily conditions associated with impaired immunosystem;chemical compositions containing nucleic acids for use in the manufacture of pharmaceuticals and gene therapy preparations; chemical compositions containing nucleic acids for specific and industrial research use, enzymes for use in the manufacture of pharmaceuticals and gene therapy preparations, in vitro chemical reagents for scientific or medical research use for analysis, microorganisms, cell cultures, plasmids and cultures in microorganisms, deo-oxyribonucleic acids sequences, cloning vehicles and recombinant deo-oxyribonucleic acid variations thereof, all for in vivo use; and chemical compositions containing enzymes for use in the manufacture of pharmaceuticals and gene therapy preparation;scientific and medical research and development; medical services; genetic engineering services, biotechnology services, namely, research and development of new products in the field of biotechnology and gene therapy; |
| MACROGEN | EYETECH PHARMACEUTICALS, INC. | 3 TIMES SQUARE 12TH FLOOR NEW YORK NY 10036 | Clinical medical reagents for use in gene therapy; pharmaceutical preparations for use in gene therapy; therapeutic compositions containing liposome reagents suitable for gene therapy; therapeutic compositions containing nucleic acid for gene therapy; pharmaceutical preparations containing nucleic acid for a system delivering genes to non-dividing cells for use in the treatment of viral and bacterial infections, cancer, HIV and AIDS related infections, leukemia and bodily conditions associated with impaired immunosystem;chemical compositions containing nucleic acids for use in the manufacture of pharmaceuticals and gene therapy preparations; chemical compositions containing nucleic acids for specific and industrial research use, enzymes for use in the manufacture of pharmaceuticals and gene therapy preparations, in vitro chemical reagents for scientific or medical research use for analysis, microorganisms, cell cultures, plasmids and cultures in microorganisms, deo-oxyribonucleic acids sequences, cloning vehicles and recombinant deo-oxyribonucleic acid variations thereof, all for in vivo use; and chemical compositions containing enzymes for use in the manufacture of pharmaceuticals and gene therapy preparation;scientific and medical research and development; medical services; genetic engineering services, biotechnology services, namely, research and development of new products in the field of biotechnology and gene therapy; |
| METXIA | Oxford BioMedica plc | Windrush Court, Transport Way Oxford OX46LT United Kingdom | CLINICAL MEDICAL REAGENTS FOR USE IN GENE THERAPY; PHARMACEUTICAL PREPARATIONS FOR USE IN GENE THERAPY; THERAPEUTIC COMPOSITIONS CONTAINING LIPSOME REAGENTS SUITABLE FOR GENE THERAPY; THERAPEUTIC COMPOSITIONS CONTAINING NUCLEIC ACID FOR GENE THERAPY; PHARMACEUTICAL PREPARATIONS CONTAINING NUCLEIC ACIDS FOR USE IN THE TREATMENT OF VIRAL AND BACTERIAL INFECTIONS, CANCER, HIV AND AIDS RELATED INFECTIONS AND BODILY CONDITIONS ASSOCIATED WITH IMPAIRED IMMUNOSYSTEMS; PHARMACEUTICAL PREPARATIONS IN THE FIELD OF GENE THERAPY; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CANCER;CHEMICAL COMPOSITIONS CONTAINING NUCLEIC ACIDS FOR USE IN THE MANUFACTURE OF PHARMACEUTICALS AND RETROVIRAL VECTOR PREPARATIONS;INSTRUMENTS AND APPARATUS FOR THE ADMINISTRATION OF GENE THERAPY AND GENE THERAPY PRODUCTS, NAMELY, SYRINGES, SCALPELS, CATHETERS, AND TUBES FOR THE ADMINISTRATION OF GENE THERAPY PRODUCTS; |
| NAV | REGENXBIO INC. | 9804 Medical Center Drive Rockville MD 20850 | Clinical medical reagents for use in gene therapy; pharmaceutical preparations for use in gene therapy; therapeutic pharmaceutical compositions that include recombinant adenoassociated viral (rAAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy, RNA interference (RNAi), and cell therapy; pharmaceutical preparations containing adeno-associated virus (AAV) vectors and nucleic acid for a system delivering genes to biological cells for use in the treatment of diseases, sicknesses, and disorders, namely, neurodegenerative disorders, metabolic and hematologic disorders, cardiovascular, oncologic and ocular diseases;NUCLEIC ACID VECTORS ; NUCLEIC ACID VIRUS; |
| OXFORD BIOMEDICA | Oxford BioMedica (UK) Limited | Transport Way Windrush Court Oxford OX4 6LT United Kingdom | Clinical medical reagents for use in gene therapy; pharmaceutical preparations for use in gene therapy; therapeutic compositions containing retroviral vector preparations and/or nucleic acid suitable for gene therapy; retroviral vector preparations for use in gene therapy; pharmaceutical preparations containing a retroviral vector delivering genes to cells for use in the treatment of viral and bacterial infections, cancer, HIV and AIDS, neurodegenerative diseases, diseases of the eye, leukemia and bodily conditions associated with impaired immunosystems; Gene therapy and prophylactic products, namely, gene delivery pharmaceuticals; small molecules, vaccines, biologics, enzymes and enzyme preparations all for medical treatment purposes; pharmaceuticals for medical purposes for the delivery of genes to cells; viral, retroviral and non-viral vectors, all for medical purposes in gene therapy; pharmaceutical and biochemical preparations for the treatment or prevention of cancer, infectious disease, fungal diseases, diseases caused by parasites, namely, hookworms, pinworms, roundworms, tapeworms, flukes, giardia, entameoba, cryptosporidium, toxoplasmosis, sleeping sickness, trichuriasis, isosporiasis, malaria, parasitic skin disease and leishmaniasis, eye diseases, diseases of the central and peripheral nervous systems, namely, ataxia, dementia, epilepsy, Alzheimer's, cerebral palsy, stroke, motor neuron disease, Parkinson's disease, spinal injury, avulsion injury and peripheral neuropathies, cardiovascular disease, diseases affecting the immune system, namely, cancer, Crohn's disease, AIDS, HIV, lupus, celiac disease, diabetes, Grave's disease, Guillain-Barré syndrome, Addison's disease, Hashimoto's disease, myasthenia gravis, narcolepsy, pernicious anaemia, rheumatoid arthritis, psoriasis, ulcerative colitis, immunodeficiency and inflammatory diseases, inherited diseases, namely, genetic disorders, hemophilia, cystic fibrosis and Huntingdon's, single gene disorders, bone and blood diseases and reproductive system disorders; pharmaceutical and biochemical preparations for contraceptive purposes; pre-filled vials for medical purposes and for pharmaceutical and biochemical preparations, for use in gene therapy and for the treatment or prevention of cancer, infectious disease, fungal diseases, diseases caused by parasites, namely, hookworms, pinworms, roundworms, tapeworms, flukes, giardia, entameoba, cryptosporidium, toxoplasmosis, sleeping sickness, trichuriasis, isosporiasis, malaria, parasitic skin disease and leishmaniasis, eye diseases, diseases of the central and peripheral nervous systems, namely, ataxia, dementia, epilepsy, Alzheimer's, cerebral palsy, stroke, motor neuron disease, Parkinson's disease, spinal injury, avulsion injury and peripheral neuropathies, cardiovascular disease, diseases affecting the immune system, namely, cancer, Crohn's disease, AIDS, HIV, lupus, celiac disease, diabetes, Grave's disease, Guillain-Barré syndrome, Addison's disease, Hashimoto's disease, myasthenia gravis, narcolepsy, pernicious anaemia, rheumatoid arthritis, psoriasis, ulcerative colitis, immunodeficiency and inflammatory diseases, inherited diseases, namely, genetic disorders, hemophilia, cystic fibrosis and Huntingdon's, single gene disorders, bone and blood diseases and reproductive system disorders;Chemical compositions containing nucleic acids for use in the manufacture of pharmaceuticals and retroviral vector preparations; Chemicals for use in industry and science; enzymes for scientific and research purposes; biochemicals, namely, precursors for in vitro genetic engineering use; polypeptides for in vitro research use, monoclonal antibodies for in vitro scientific or research use; chemicals for use in the purification of proteins for in vitro use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; micro-organisms for laboratory and scientific research use, viruses for laboratory and scientific research use, cell cultures for laboratory and scientific research use, plasmids and cultures of micro-organisms for laboratory and scientific research use, nucleic acid sequences for laboratory and scientific research use, cloning vehicles in the nature of plasmids, microbes and chemical reagents for DNA cloning for laboratory and scientific research use, chemicals for laboratory, scientific and biotechnology research and development and recombinant nucleic acid variations thereof for laboratory and scientific research use, namely, in vitro and in vivo use;Medical services; advisory services relating to vaccination regimes; advisory services relating to the treatment, relief and/or prevention of cancer, infectious diseases, fungal diseases, diseases caused by parasites, namely, hookworms, pinworms, roundworms, tapeworms, flukes, giardia, entameoba, cryptosporidium, toxoplasmosis, sleeping sickness, trichuriasis, isosporiasis, malaria, parasitic skin disease and leishmaniasis, eye diseases, diseases of the central and peripheral nervous systems, namely, ataxia, dementia, epilepsy, Alzheimer's, cerebral palsy, stroke, motor neuron disease, Parkinson's disease, spinal injury, avulsion injury and peripheral neuropathies, cardiovascular disease, diseases affecting the immune system, namely, cancer, Crohn's disease, AIDS, HIV, lupus, celiac disease, diabetes, Grave's disease, Guillain-Barré syndrome, Addison's disease, Hashimoto's disease, myasthenia gravis, narcolepsy, pernicious anaemia, rheumatoid arthritis, psoriasis, ulcerative colitis, immunodeficiency and inflammatory diseases, inherited diseases, namely, genetic disorders, hemophilia, cystic fibrosis and Huntingdon's, single gene disorders, bone and blood diseases and reproductive system disorders and contraceptives;OXFORD;Scientific, pharmaceutical and medical research and development; genetic engineering services, biotechnology services, namely, research and development for new products in the field of biotechnology, advisory services relating to gene therapy products and clinical trials, conducting clinical trials; |
| PLENTI | Oxford BioMedica plc | Windrush Court, Transport Way Oxford OX46LT United Kingdom | clinical medical reagents for use in gene therapy, pharmaceutical preparations for use in gene therapy,enzymes and enzyme preparations for medical purpose, for use in gene delivery and cloning technology, retroviral vector and retroviral vector manufacturing preparations for use in gene delivery and cloning technology;chemicals for use in the manufacture of viruses, vectors, pharmaceuticals and retroviral vector preparations for use in industry, science and medical science; enzymes and chemical products for in vitro use in laboratories and for analysis in and development of gene delivery technology; micro organisms, cell cultures, plasmids and cultures of micro organisms, deoxyribonucleic acid sequences, cloning vehicles and recombinant deoxyribonucleic acid and variations thereof, all for in vivo or ex vivo use in gene delivery technology and cloning technology;Medical Services;scientific and medical research and development, and product development; genetic engineering services, biotechnology services, namely research and development of new products for others in the field of gene technology and gene therapy; |
| PLENTIVECTOR | Oxford BioMedica plc | Windrush Court, Transport Way Oxford OX46LT United Kingdom | Clinical medical reagents for use in gene therapy; pharmaceutical preparations for use in gene therapy; therapeutic compositions containing liposome reagents suitable for gene therapy; therapeutic compositions containing nucleic acid for gene therapy; pharmaceutical preparations containing nucleic acid for a system delivering genes to non-dividing cells for use in the treatment of viral and bacterial infections, cancer, HIV and AIDS related infections, leukemia and bodily conditions associated with impaired immunosystem;Chemical compositions containing nucleic acids for use in the manufacture of pharmaceutical and retroviral vector preparations;medical services;Scientific and medical product research and development, genetic engineering services for scientific and medical research use, biotechnology services, namely, research and development of new products in the field of biotechnology, genetic engineering services for scientific and medical research use; |
| PONY | Oxford BioMedica plc | Windrush Court, Transport Way Oxford OX46LT United Kingdom | clinical medical reagents for use in gene therapy, pharmaceutical preparations for use in gene therapy, enzymes and enzyme preparations for medical purpose, for use in gene delivery and cloning technology, retroviral vector and retroviral vector manufacturing preparations for use in gene delivery and cloning technology, none of the aforesaid goods relating to the treatment of equidae;chemicals for use in the manufacture of viruses, vectors, pharmaceuticals and retroviral vector preparations for use in industry, science and medical science; enzymes and chemical products for in vitro use in laboratories and for analysis in and development of gene delivery technology; micro organisms, cell cultures, plasmids and cultures of micro organisms, deoxyribonucleic acid sequences, cloning vehicles and recombinant deoxyribonucleic acid and variations thereof, all for in vivo or ex vivo use in gene delivery technology and cloning technology, none of the aforesaid goods relating to the treatment of equidae;medical services;scientific and medical research and development, and product development; genetic engineering services, biotechnology services, namely research and development of new products for others in the field of gene technology and gene therapy, none of the aforesaid services relating to the treatment of equidae; |
| PROCASTAT | Oxford BioMedica plc | Windrush Court, Transport Way Oxford OX46LT United Kingdom | clinical medical reagents for use in gene therapy; pharmaceutical preparations for use in gene therapy; therapeutic compositions containing liposome reagents suitable for gene therapy; therapeutic compositions containing nucleic acid for gene therapy; pharmaceutical preparations of the treatment of prostate cancer; pharmaceutical preparations containing nucleic acid for use in the treatment of prostate cancer;instruments and apparatus for the administration of gene therapy, namely, syringes, scalpels, catheters and tubes, for medical services surgical and medical apparatus and instruments, namely, syringes, scalpels, catheters, tubes for medical services; |
| PROCASTAT | Oxford BioMedica plc | Windrush Court, Transport Way Oxford OX46LT United Kingdom | Clinical medical reagents for use in gene therapy; pharmaceutical preparations, namely, vaccines for use in gene therapy; therapeutic compositions containing liposome reagents or nucleic acid suitable for gene therapy for use in the treatment of cancer and auto-immune disorders; pharmaceutical preparations containing nucleic acids for use in the treatment of viral and bacterial infections, cancer, HIV and AIDS-related infections and bodily conditions associated with impaired immunosystems, single gene disorders, hemophilia, blood disorders, vascular disorders and disorders arising from inappropriate vascularization diseases of the nervous system, cardiac disorders, inflammatory and auto-immune diseases; pharmaceutical preparations and vaccines for use in the treatment of cancer, single gene disorders, hemophilia, blood disorders, vascular disorders and disorders arising from inappropriate vascularization, diseases of the nervous system, cardiac disorders, inflammatory and auto-immune diseases; enzymes and enzymatic preparations for medical use in the treatment of bacterial infections; retroviral vector preparations for medical use in the treatment of cancer; and chemotherapeutics for medical use;Instruments and apparatus for the administration of gene therapy products, namely, vials, syringes, injectors, catheters and tubes; and surgical and medical apparatus and instruments, namely, scalpels, knives, forceps and surgical clips; |
| PROSAVIN | Oxford BioMedica plc | Windrush Court, Transport Way Oxford OX46LT United Kingdom | clinical medical reagents for use in gene therapy; pharmaceutical preparations for use in gene therapy; therapeutic compositions containing liposome reagents suitable for gene therapy; therapeutic compositions containing nucleic acid for gene therapy; pharmaceutical preparations of the treatment of prostate cancer; pharmaceutical preparations containing nucluic acid for use in the treatment of prostate cancer;instruments and apparatus for the administration of gene therapy, namely, syringes, scalpels, catheters and tubes, for medical services surgical and medical apparatus and instruments, namely, syringes, scalpels, catheters, tubes for medical services; |
| SPECIAL-T MARKER | MEDICAL ANALYSIS SYSTEMS, INC. | 5300 Adolfo Road Camarillo CA 91362 | clinical medical reagents for use in quality control of cancer antigen testing assays;SPECIAL T MAKER;MARKER; |
| TROVAX | Oxford BioMedica pIc | Transport Way Windrush Court Oxford OX4 6LT United Kingdom | clinical medical reagents for use in gene therapy and prophylaxis pharmaceutical substances and preparations for use in gene therapy and prophylaxis, vaccines, enzymes and enzymes preparations for medical purposes; therapeutic compositions containing nucleic acids for gene therapy and prophylaxis; gene therapy and prophylaxis vector preparations;Reagents for scientific or medical research use in gene therapy, therapeutic compositions containing liposome reagents suitable for gene therapy, therapeutic compositions containing nucleic acids for gene therapy, pharmaceutical preparations containing nucleic acids for use in the treatment of viral and bacterial infections, cancer and bodily conditions associated with impaired immunosystems;[Instruments and apparatus for the administration of gene therapy and prophylaxis, syringes, injectors for medical purposes]; |
| XANTOS | XANTOS Biomedicine GmbH | Fraunhoferstrasse 22 D-82152 Martinsried Germany | CLINICAL MEDICAL REAGENTS FOR USE IN THE BACTERIOLOGICAL, MEDICAL AND VETERINARY FIELDS;REAGENTS FOR SCIENTIFIC OR MEDICAL RESEARCH USE, INCLUDING BIOCHEMICAL RESEARCH;BACTERIOLOGICAL AND CHEMICAL LABORATORY SERVICES; |
Where the owner name is not linked, that owner no longer owns the brand |
|||
Technical Examples
- A method and apparatus are provided for adjusting a dynamic range of a digital medical image for a medical imaging system. The digital medical image contains a clinical region and a non-clinical region. The method and apparatus identify the non-clinical region of the digital medical image and mask the non-clinical region therefrom to form a clinical image. The clinical image is then used to calculate a desired dynamic range for the medical imaging system. The dynamic range of the medical imaging system is adjusted accordingly. According to one embodiment, the non-clinical region is identified by dividing the digital medical image into bands of a predetermined width, generating profiles for each band and differentiating the profiles to obtain a differentiated profile of each band of a digital medical image. The differentiated profile is than analyzed to identify peaks that exceed predetermined thresholds, wherein the regions of the differentiated profile proximate the peaks exceeding the threshold correspond to non-clinical regions. Once the non-clinical regions are identified, they are masked or removed. Next, a desired image characteristic, such as maximum and minimum gray scale values, are determined for the clinical region and a desired dynamic range for the image is obtained based on the image characteristics of the clinical region. In an alternative embodiment, a histogram is used to identify the non-clinical regions which are subsequently masked from the digital medical image.